{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:20:27Z","timestamp":1787923227295,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,22]],"date-time":"2027-06-22T00:00:00Z","timestamp":1813622400000},"content-version":"am","delay-in-days":294,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalimaging.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clinimag.2026.110876","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:24:48Z","timestamp":1781886288000},"page":"110876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Quantitative molecular breast imaging for early prediction of neoadjuvant systemic therapy response in locally advanced breast cancer patients"],"prefix":"10.1016","volume":"137","author":[{"given":"Miral M.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz E.","family":"Adrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheenu S.","family":"Kappadath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Moseley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Whitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaiane M.","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinimag.2026.110876_bb0005","series-title":"Key statistics for breast cancer","author":"Society","year":"2026"},{"issue":"4","key":"10.1016\/j.clinimag.2026.110876_bb0010","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2214\/AJR.18.20628","article-title":"Comparison of (99m)Tc-Sestamibi Molecular Breast Imaging and Breast MRI in patients with invasive breast cancer receiving neoadjuvant chemotherapy","volume":"213","author":"Hunt","year":"2019","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clinimag.2026.110876_bb0015","author":"Sikov"},{"issue":"2","key":"10.1016\/j.clinimag.2026.110876_bb0020","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2214\/AJR.16.17223","article-title":"Multimodality imaging for evaluating response to neoadjuvant chemotherapy in breast cancer","volume":"208","author":"Rauch","year":"2017","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.clinimag.2026.110876_bb0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.21037\/cco.2016.03.26","article-title":"The timing of breast and axillary surgery after neoadjuvant chemotherapy for breast cancer","volume":"5","author":"Al-Hilli","year":"2016","journal-title":"Chin Clin Oncol"},{"issue":"11","key":"10.1016\/j.clinimag.2026.110876_bb0030","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1245\/s10434-011-1919-5","article-title":"Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients","volume":"18","author":"Croshaw","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clinimag.2026.110876_bb0035","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/964863","article-title":"Which imaging modality is superior for prediction of response to neoadjuvant chemotherapy in patients with triple negative breast cancer?","volume":"2013","author":"Atkins","year":"2013","journal-title":"J Oncol"},{"issue":"suppl 1","key":"10.1016\/j.clinimag.2026.110876_bb0040","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1016\/S0720-048X(12)70061-X","article-title":"Neoadjuvant chemotherapy\u2014monitoring: clinical examination, ultrasound, mammography, MRI, elastography: only one, only few or all?","volume":"81","author":"Schulz-Wendtland","year":"2012","journal-title":"Eur J Radiol"},{"issue":"5","key":"10.1016\/j.clinimag.2026.110876_bb0045","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1245\/s10434-015-4403-9","article-title":"Role of imaging in neoadjuvant therapy for breast cancer","volume":"22","author":"Dialani","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.clinimag.2026.110876_bb0050","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1515\/raon-2016-0007","article-title":"Diagnostic accuracy of MRI to evaluate tumour response and residual tumour size after neoadjuvant chemotherapy in breast cancer patients","volume":"50","author":"Bouzon","year":"2016","journal-title":"Radiol Oncol"},{"issue":"1","key":"10.1016\/j.clinimag.2026.110876_bb0055","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2214\/AJR.09.3908","article-title":"Accuracy of MRI in prediction of pathologic complete remission in breast cancer after preoperative therapy: a meta-analysis","volume":"195","author":"Yuan","year":"2010","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.clinimag.2026.110876_bb0060","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/bjc.2013.473","article-title":"Meta-analysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapy","volume":"109","author":"Marinovich","year":"2013","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.clinimag.2026.110876_bb0065","first-page":"699","article-title":"Predicting response to neoadjuvant chemotherapy in breast cancer: molecular imaging, systemic biomarkers and the cancer metabolome (review)","volume":"20","author":"Chuthapisith","year":"2008","journal-title":"Oncol Rep"},{"issue":"2","key":"10.1016\/j.clinimag.2026.110876_bb0070","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1148\/radiol.2017170180","article-title":"Imaging neoadjuvant therapy response in breast cancer","volume":"285","author":"Fowler","year":"2017","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.clinimag.2026.110876_bb0075","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00259-011-2054-z","article-title":"Lexicon for standardized interpretation of gamma camera molecular breast imaging: observer agreement and diagnostic accuracy","volume":"39","author":"Conners","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1016\/j.clinimag.2026.110876_bb0080","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1002\/mp.12403","article-title":"Quantitation of tumor uptake with molecular breast imaging","volume":"44","author":"Bache","year":"2017","journal-title":"Med Phys"},{"issue":"28","key":"10.1016\/j.clinimag.2026.110876_bb0085","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1200\/JCO.2007.10.6823","article-title":"Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy","volume":"25","author":"Symmans","year":"2007","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clinimag.2026.110876_bb0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clbc.2017.06.008","article-title":"Is Technetium-99m Sestamibi Imaging able to predict pathologic nonresponse to neoadjuvant chemotherapy in breast cancer? A meta-analysis evaluating current use and shortcomings","volume":"18","author":"Collarino","year":"2018","journal-title":"Clin Breast Cancer"},{"issue":"11","key":"10.1016\/j.clinimag.2026.110876_bb0095","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2410::AID-CNCR16>3.0.CO;2-K","article-title":"Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammography","volume":"85","author":"Mankoff","year":"1999","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.clinimag.2026.110876_bb0100","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/MNM.0000000000000331","article-title":"Technetium-99m methoxyisobutylisonitrile scintimammography for monitoring and early prediction of breast cancer response to neoadjuvant chemotherapy","volume":"36","author":"Novikov","year":"2015","journal-title":"Nucl Med Commun"},{"issue":"5","key":"10.1016\/j.clinimag.2026.110876_bb0105","doi-asserted-by":"crossref","first-page":"050901","DOI":"10.1118\/1.4802733","article-title":"Nuclear imaging of the breast: translating achievements in instrumentation into clinical use","volume":"40","author":"Hruska","year":"2013","journal-title":"Med Phys"},{"issue":"12","key":"10.1016\/j.clinimag.2026.110876_bb0110","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/RLU.0000000000000248","article-title":"Tc-99m-sestamibi using a direct conversion molecular breast imaging system to assess tumor response to neoadjuvant chemotherapy in women with locally advanced breast cancer","volume":"38","author":"Mitchell","year":"2013","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1016\/j.clinimag.2026.110876_bb0115","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1148\/radiol.2015150013","article-title":"Neoadjuvant chemotherapy for breast cancer: functional tumor volume by MR imaging predicts recurrence-free survival-results from the ACRIN 6657\/CALGB 150007 I-SPY 1 TRIAL","volume":"279","author":"Hylton","year":"2016","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.clinimag.2026.110876_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15041025","article-title":"Assessment of response to neoadjuvant systemic treatment in triple-negative breast cancer using functional tumor volumes from longitudinal dynamic contrast-enhanced MRI","volume":"15","author":"Panthi","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.clinimag.2026.110876_bb0125","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1148\/radiol.12110748","article-title":"Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy\u2014results from ACRIN 6657\/I-SPY TRIAL","volume":"263","author":"Hylton","year":"2012","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.clinimag.2026.110876_bb0130","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2214\/AJR.19.21924","article-title":"Breast MRI: Is faster better?","volume":"214","author":"Milon","year":"2020","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.clinimag.2026.110876_bb0135","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.2214\/AJR.14.13306","article-title":"Diagnostic workup and costs of a single supplemental molecular breast imaging screen of mammographically dense breasts","volume":"204","author":"Hruska","year":"2015","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.clinimag.2026.110876_bb0140","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2214\/AJR.21.26349","article-title":"Implementation of abbreviated breast MRI for screening: AJR Expert Panel narrative review","volume":"218","author":"Grimm","year":"2022","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"10.1016\/j.clinimag.2026.110876_bb0145","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.1993.11.11.2101","article-title":"Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation","volume":"11","author":"Wahl","year":"1993","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clinimag.2026.110876_bb0150","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10549-011-1780-z","article-title":"Is 18F-FDG PET accurate to predict neoadjuvant therapy response in breast cancer? A meta-analysis","volume":"131","author":"Wang","year":"2012","journal-title":"Breast Cancer Res Treat"}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707126001683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707126001683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:25:08Z","timestamp":1787919908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899707126001683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"alternative-id":["S0899707126001683"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2026.110876","relation":{},"ISSN":["0899-7071"],"issn-type":[{"value":"0899-7071","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative molecular breast imaging for early prediction of neoadjuvant systemic therapy response in locally advanced breast cancer patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2026.110876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110876"}}